We are live on ! Find out more
ONCS

OncoSec Medical

Delisted

ONCS was delisted on the 23rd of June, 2023.

25 hedge funds and large institutions have $3.86M invested in OncoSec Medical in 2022 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 8 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.23% less ownership

Funds ownership: 13.45% → 13.22% (-0.23%)

11% less funds holding

Funds holding: 28 → 25 (-3)

50% less repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 8

66% less capital inflows, than outflows

Capital inflows: $43.4K | Capital outflows: $128K

75% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 4

Holders
25
Holders Change
-3
Holders Change %
-10.71%
% of All Funds
0.42%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
4
Reduced
8
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

ONCS Hedge Fund Activity: Q2 2022 in Review

25 of the 5,965 institutional investors tracked by Wall St. Rank reported a position in OncoSec Medical (ONCS) for Q2 2022, worth a combined $3.86M — down 37% from $6.09M a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of ONCS and 1 opened new positions — a net loss of 3 holders — while 8 trimmed existing stakes and 4 added.

The largest buyer was Renaissance Technologies, adding an estimated $20.9K. The largest seller was BlackRock, cutting an estimated $43.7K.

  • 25 institutional investors held OncoSec Medical (ONCS) as of Q2 2022, down from 28 in Q1 2022.
  • Funds reported $3.86M of OncoSec Medical stock for Q2 2022, down 37% quarter-over-quarter.
  • 1 fund opened new OncoSec Medical positions in Q2 2022 and 4 closed out, a net change of -3 holders.
  • The largest OncoSec Medical buyer in Q2 2022 was Renaissance Technologies, an estimated $20.9K added.
  • The largest OncoSec Medical seller in Q2 2022 was BlackRock, an estimated $43.7K sold.

Based on aggregated 13F filings for Q2 2022.